NCT01416935

Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation

Anti-Arrhythmic Medication (Amiodarone) Post Surgical Ablation for Atrial Fibrillation - Is it Necessary?

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 186 (actual)
• Sponsor: Inova Health Care Services · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether anti arrhythmic medication, specifically Amiodarone, is required during the first three months post surgical ablation. Hypothesis: Amiodarone will not be required during the first three months as verified by no increase in rehospitalizations for recurrent Atrial Fibrillation, and report of sinus rhythm at surgical follow up (approximately 3 weeks from date of surgery), 6 weeks and 12 weeks to include patients' first follow up with cardiologist at approximately 3 months post surgery.

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
OTHER	No Amiodarone	This is a randomized study whereby patients who would routinely/usually be scheduled to receive Amiodarone as their anti-arrhythmic medication post surgical ablation will be randomly assigned to receive Amiodarone or no Amiodarone, but all other medications would remain as prescribed for patients following surgical ablation which will include beta blockade therapy unless contraindicated which is an American Heart Associated and Heart Rhythm Society recognized treatment.

Timeline

• Start date: 2011-01-01
• Primary completion: 2015-01-01
• Completion: 2016-07-01
• First posted: 2011-08-15
• Last updated: 2022-01-20

Locations

1 site across 1 country: United States